Nutrien Ltd. (NTR) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$2.72	$2.61	-4.0%	—	$10.8B	—
Q1 26	$0.55	$0.51	-7.3%	—	$6B	—
Q4 25	$1.32	$1.35	+2.3%	—	$5.3B	—
Q3 25	$0.96	$0.97	+1.0%	—	$6B	—
Q2 25	$2.42	$2.65	+9.5%	—	$10.4B	—
Q1 25	$0.3	$0.11	-63.3%	—	$5.1B	—
Q4 24	$0.36	$0.31	-13.9%	—	$5.1B	—
Q3 24	$0.45	$0.39	-13.3%	—	$5.3B	—
Q2 24	$2.19	$2.34	+6.8%	—	$10.2B	—
Q1 24	$0.38	$0.46	+21.1%	—	$5.4B	—
Q4 23	$0.65	$0.37	-43.1%	—	$5.7B	—
Q3 23	$0.66	$0.35	-47.0%	—	$5.6B	—
Q2 23	$2.79	$2.53	-9.3%	—	$11.7B	—
Q1 23	$1.47	$1.11	-24.5%	—	$6.1B	—
Q4 22	$2.62	$2.02	-22.9%	—	$7.5B	—
Q3 22	$3.97	$2.51	-36.8%	—	$8.2B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$4.66	—	—	$26.9B	—
FY24	—	$1.36	—	—	$26B	—
FY23	—	$2.53	—	—	$29.1B	—
FY22	—	$14.2	—	—	$37.9B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$4.5B	$4.5B	$19.6B	$20.1B	$20.9B	$27.7B	$37.9B	$29.1B	$26B	$26.9B
YoY change	-29%	+2.04%	+331.8%	+2.28%	+4.1%	+32.5%	+36.7%	-23.3%	-10.6%	+3.52%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	4.5B	4.5B	19.6B	20.1B	20.9B	27.7B	37.9B	29.1B	26B	26.9B
Cost of revenue	3.6B	3.9B	14.2B	14.6B	15.7B	18.3B	22.5B	20.6B	18.4B	18.5B
Gross profit	830M	694M	5.4B	5.5B	5.2B	9.4B	15.4B	8.5B	7.5B	8.3B
Gross margin	18.6%	15.3%	27.5%	27.4%	25.1%	34%	40.7%	29.2%	29%	31%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	212M	214M	2.9B	3B	3.3B	3.8B	4.1B	4.1B	4.2B	4.1B
Operating expenses	215M	217M	2.9B	3.1B	3.3B	3.8B	4.1B	4.2B	4.3B	4.1B
Operating income	491M	334M	2.3B	2.2B	1.7B	5.1B	10.2B	3.9B	3B	3.9B
Operating margin	11%	7.35%	11.5%	10.9%	8.25%	18.5%	26.9%	13.3%	11.4%	14.4%
Non-operating income, net	-32M	-125M	-1.9B	-335M	-822M	-483M	626M	-1.1B	-1.1B	-133M
Pretax income	243M	-29M	-124M	1.3B	382M	4.2B	10.2B	2B	1.1B	3B
Income tax	44M	-183M	-93M	316M	-77M	989M	2.6B	670M	436M	752M
Net income	323M	327M	3.6B	992M	459M	3.2B	7.7B	1.3B	700M	2.3B
Net margin	7.25%	7.19%	18.2%	4.94%	2.2%	11.5%	20.3%	4.41%	2.7%	8.54%
EBITDA	1.2B	1B	3.9B	4B	3.6B	6.9B	12.1B	5.9B	5.2B	6B
EPS	1	0.97	5.72	1.7	0.81	5.53	14.2	2.53	1.36	4.66
Diluted EPS	1	0.97	5.72	1.7	0.81	5.52	14.2	2.53	1.36	4.66

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	5.6B	5.7B	5.4B	10.2B	5.3B	5.1B	5.1B	10.4B	6B	5.3B	6B	10.8B
Cost of revenue	4B	3.9B	3.9B	7.2B	3.8B	3.5B	3.8B	7.3B	4B	3.5B	4.4B	7.6B
Gross profit	1.6B	1.8B	1.5B	2.9B	1.5B	1.6B	1.3B	3.2B	2B	1.9B	1.6B	3.3B
Gross margin	28.9%	31.2%	28.5%	28.7%	28%	31.1%	25.9%	30.4%	32.7%	35.4%	27.2%	30.1%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	992M	1.1B	954M	1.2B	977M	1.1B	956M	1.2B	973M	1B	1.1B	1.1B
Operating expenses	996M	1.1B	957M	1.2B	1.2B	1.1B	961M	1.2B	963M	1B	1B	1.2B
Operating income	535M	467M	512M	1.7B	265M	471M	291M	1.9B	877M	771M	507M	2B
Operating margin	9.5%	8.25%	9.5%	16.4%	4.96%	9.27%	5.71%	18.5%	14.6%	14.4%	8.39%	18.4%
Non-operating income, net	-150M	-174M	-93M	-824M	-69M	-74M	-65M	-145M	-70M	150M	-147M	-212M
Pretax income	179M	80M	240M	682M	12M	202M	47M	1.6B	637M	738M	184M	1.6B
Income tax	97M	-96M	75M	290M	-13M	84M	28M	398M	168M	158M	45M	382M
Net income	82M	176M	165M	392M	25M	118M	19M	1.2B	469M	580M	139M	1.2B
Net margin	1.46%	3.11%	3.06%	3.86%	0.47%	2.32%	0.37%	11.8%	7.81%	10.9%	2.3%	11.3%
EBITDA	1.1B	915M	1.1B	2.2B	858M	1.1B	824M	2.5B	1.4B	1.3B	1B	2.5B
EPS	0.15	0.35	0.32	0.78	0.04	0.23	0.02	2.51	0.96	1.18	0.27	2.53
Diluted EPS	0.15	0.35	0.32	0.78	0.04	0.23	0.02	2.5	0.96	1.18	0.27	2.53

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	—	27.9B	27.4B	42.8B	39.3B	28B	22.1B	30B	34.3B
Enterprise value	—	—	—	38.3B	37.3B	53.2B	50.4B	39.6B	34.1B	41.3B	46.2B
Shares outstanding	335.6M	336M	624.9M	582.3M	569.7M	569.7M	538.5M	496.4M	494.2M	486.3M	486.3M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	28.1	59.8	13.5	5.12	21.8	31.6	13.1	14.6
P/S	—	—	—	1.39	1.31	1.55	1.04	0.96	0.85	1.12	1.26
P/B	—	—	—	1.22	1.22	1.81	1.52	1.11	0.9	1.18	1.33
EV/EBITDA	—	—	—	9.7	10.4	7.69	4.17	6.75	6.5	6.88	8.17
EV/Sales	—	—	—	1.91	1.79	1.92	1.33	1.36	1.31	1.54	1.69
Earnings yield	—	—	—	3.56%	1.67%	7.42%	19.5%	4.58%	3.17%	7.65%	6.84%
FCF yield	—	—	—	6.36%	6.47%	4.67%	14.3%	8.57%	6.24%	6.67%	4.66%
PEG	—	—	—	—	—	—	—	—	—	—	18.4

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	18.6%	15.3%	27.5%	27.4%	25.1%	34%	40.7%	29.2%	29%	31%	30.1%
Operating margin	11%	7.35%	11.5%	10.9%	8.25%	18.5%	26.9%	13.3%	11.4%	14.4%	17.5%
Net margin	7.25%	7.19%	18.2%	4.94%	2.2%	11.5%	20.3%	4.41%	2.7%	8.54%	8.72%
ROE	3.94%	3.94%	14.6%	4.34%	2.05%	13.4%	29.7%	5.09%	2.86%	9.06%	9.44%
ROA	1.87%	1.92%	7.85%	2.12%	0.97%	6.36%	14.1%	2.43%	1.35%	4.39%	4.31%
ROIC	3.15%	2.64%	7.23%	5%	5.34%	11.5%	20.7%	6.88%	5%	7.95%	8.37%
Return on tangible assets	1.91%	1.96%	19.6%	5.52%	2.55%	15.3%	30.4%	5.32%	2.9%	9.3%	9.24%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.82	2.07	1.4	1.17	1.35	1.11	1.14	1.17	1.15	1.34	1.39
Quick ratio	0.37	1.58	0.81	0.62	0.77	0.6	0.61	0.65	0.63	0.7	0.86
Debt / equity	0.56	0.53	0.38	0.49	0.51	0.46	0.46	0.5	0.52	0.47	0.49
Debt / assets	0.27	0.26	0.2	0.24	0.24	0.22	0.22	0.24	0.25	0.23	0.24
Net debt / EBITDA	3.82	4.29	1.79	2.64	2.75	1.5	0.91	1.98	2.28	1.88	1.9
Interest coverage	2.11	0.88	0.78	3.34	1.73	10	20.7	3.55	2.54	5.18	5.25
Effective tax rate	18.1%	0%	0%	24.2%	0%	23.7%	25%	34.3%	38.4%	24.7%	23.8%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	13.3	13.5	31.4	34.5	36.7	48.6	70.4	58.5	52.6	55.3	56.6
EPS (basic)	1	0.97	5.72	1.7	0.81	5.53	14.2	2.53	1.36	4.66	4.66
EPS (diluted)	1	0.97	5.72	1.7	0.81	5.52	14.2	2.53	1.36	4.66	4.92
Book value per share	24.4	24.7	39.1	39.3	39.3	41.6	48	50.8	49.5	52.2	54.2
FCF per share	1.09	1.71	0.87	3.05	3.11	3.51	10.5	4.82	2.79	4.12	4.35
Cash per share	0.1	0.35	3.7	1.15	2.55	0.88	1.67	1.9	1.73	1.44	1.93
Capex per share	2.66	1.94	2.25	2.97	2.5	—	—	—	—	4.12	4.37

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	20%	14.3%	7.16%	8.6%	6.81%	—	—	—	—	7.46%	7.43%
Capex / operating cash flow	78.3%	66.7%	918.3%	54.3%	59.2%	—	—	—	—	50%	50.1%
Payout ratio	250.5%	100.9%	26.6%	103%	224.4%	32.9%	13.4%	80.5%	151.4%	46.2%	44.3%
Dividend yield	—	—	—	3.66%	3.75%	2.44%	2.62%	3.69%	4.79%	3.53%	3.06%

Yield

3.06%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.55

ex-dividend Jun 30, 2026

Payout ratio

44%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jun 30, 2026	$0.55
Mar 31, 2026	$0.55
Jun 30, 2025	$0.545
Mar 31, 2025	$0.545
Dec 31, 2024	$0.54
Sep 27, 2024	$0.54
Jun 28, 2024	$0.54
Mar 27, 2024	$0.54

Split history

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$5.6B	$5.7B	$5.4B	$10.2B	$5.3B	$5.1B	$5.1B	$10.4B	$6B	$5.3B	$6B	$10.8B
YoY change	-31.2%	-24.8%	-11.8%	-12.9%	-5.03%	-10.3%	-5.36%	+2.78%	+12.3%	+5.14%	+18.5%	+3.58%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	32M	116M	2.3B	671M	1.5B	499M	901M	941M	853M	701M
Receivables	427M	390M	2.7B	3B	3B	4.7B	5.6B	4.7B	4.6B	5.1B
Inventory	768M	788M	4.9B	5B	4.9B	6.3B	7.6B	6.3B	6.1B	7B
Total current assets	1.4B	3.3B	11.7B	10.7B	11.5B	13.8B	16.3B	14.2B	13.8B	14.7B
Property, plant & equipment	6.6B	6.1B	9.2B	10.1B	9B	8.9B	10.3B	10.5B	10.2B	9.9B
Goodwill & intangibles	360M	332M	27.3B	28.8B	29.2B	29.1B	29.3B	28.7B	27.7B	27.6B
Total assets	17.3B	17B	45.5B	46.8B	47.2B	50B	54.6B	52.7B	51.8B	52.3B
Accounts payable	340M	255M	3.1B	4B	4.4B	5.2B	5.8B	5.5B	5.4B	5.5B
Short-term debt	884M	730M	1.6B	1.7B	422M	2.4B	3B	2.7B	2.9B	1.7B
Total current liabilities	1.7B	1.6B	8.3B	9.1B	8.5B	12.4B	14.3B	12.1B	12B	11B
Long-term debt	3.7B	3.7B	7.6B	9.4B	10.9B	8.5B	8.9B	9.9B	9.9B	10.3B
Total liabilities	9.1B	8.7B	21.1B	23.9B	24.8B	26.3B	28.7B	27.5B	27.4B	26.9B
Shareholders' equity	8.2B	8.3B	24.4B	22.9B	22.4B	23.7B	25.9B	25.2B	24.4B	25.4B
Total debt	4.6B	4.4B	9.2B	11.1B	11.4B	10.8B	11.9B	12.6B	12.8B	12B
Net debt	4.6B	4.3B	6.9B	10.4B	9.9B	10.3B	11B	11.6B	12B	11.3B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	554M	941M	496M	1B	520M	853M	895M	1.4B	624M	701M	777M	921M
Receivables	7.7B	4.7B	5.6B	8.1B	7.8B	4.6B	5.6B	8.1B	7.7B	5.1B	6.3B	8.7B
Inventory	5.2B	6.3B	8.2B	5.3B	4.9B	6.1B	8B	5.6B	5.3B	7B	8.7B	6.2B
Total current assets	14.1B	14.2B	15.2B	15.1B	13.9B	13.8B	15.4B	15.6B	14.5B	14.7B	16.5B	16.2B
Property, plant & equipment	—	10.5B	—	—	—	10.2B	—	—	—	9.9B	—	—
Goodwill & intangibles	28.6B	28.7B	28.5B	28B	28B	27.7B	27.7B	27.7B	27.7B	27.6B	27.6B	27.5B
Total assets	52.2B	52.7B	53.6B	53B	51.9B	51.8B	53.1B	53.3B	51.8B	52.3B	53.9B	53.6B
Accounts payable	—	5.5B	—	—	—	5.4B	—	—	—	5.5B	—	—
Short-term debt	4.7B	2.7B	3.7B	2.9B	4.3B	2.9B	3.8B	2.8B	3.4B	1.7B	4.2B	2.3B
Total current liabilities	11.3B	12.1B	13.1B	12B	11B	12B	12.6B	11.8B	10.3B	11B	13.3B	11.6B
Long-term debt	10.3B	9.9B	9.9B	10.4B	10.4B	9.9B	10.9B	10.9B	10.8B	10.3B	9.8B	10.4B
Total liabilities	27B	27.5B	28.6B	27.8B	26.9B	27.4B	29B	28.1B	26.7B	26.9B	28.7B	27.6B
Shareholders' equity	25.2B	25.2B	25B	25.2B	25B	24.4B	24.1B	25.1B	25.2B	25.4B	25.2B	25.9B
Total debt	15B	12.6B	13.6B	13.4B	14.8B	12.8B	14.7B	13.6B	14.2B	12B	13.9B	12.7B
Net debt	14.4B	11.6B	13.1B	12.4B	14.2B	12B	13.8B	12.3B	13.6B	11.3B	13.2B	11.8B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	323M	327M	-826M	992M	459M	3.2B	7.7B	1.3B	700M	2.3B
Depreciation & amortization	695M	692M	1.6B	1.8B	2B	2B	2B	2.2B	2.3B	2.4B
Stock-based compensation	2M	11M	116M	104M	69M	198M	63M	-14M	37M	163M
Change in working capital	103M	128M	-1.2B	126M	230M	-3.1B	-2.2B	879M	-164M	-685M
Operating cash flow	1.1B	976M	153M	3.2B	2.4B	2.3B	8B	4.5B	3.3B	4B
Capital expenditure	-893M	-651M	-1.4B	-1.7B	-1.4B	—	—	—	—	-2B
Investing cash flow	-895M	-652M	-1.4B	-2.7B	-1.2B	77M	-426M	-287M	21M	-1.4B
Dividends paid	-809M	-330M	-952M	-1B	-1B	-1B	-1B	-1B	-1.1B	-1.1B
Share repurchases	0	0	-1.8B	-1.9B	-160M	-1B	-4.5B	-1B	-184M	-551M
Financing cash flow	-424M	-489M	-3.7B	-2.5B	-1.3B	-3B	-4.7B	-2.1B	-1.5B	-2.8B
Net change in cash	-179M	-165M	-5B	-2B	-114M	-638M	2.9B	2.1B	1.9B	-182M
Free cash flow	367M	574M	545M	1.8B	1.8B	2B	5.6B	2.4B	1.4B	2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	82M	176M	165M	392M	25M	118M	19M	1.2B	469M	580M	139M	1.2B
Depreciation & amortization	552M	565M	565M	586M	598M	590M	571M	614M	617M	567M	606M	604M
Stock-based compensation	42M	-7M	6M	10M	1M	20M	42M	49M	28M	44M	116M	-41M
Change in working capital	1.4B	2.4B	-1.6B	-2.6B	791M	-35M	-1.4B	432M	614M	-314M	-1.5B	524M
Operating cash flow	2.2B	3.1B	-716M	-1.6B	1.6B	729M	-738M	2.5B	-426M	3B	-851M	2.5B
Capital expenditure	—	—	—	—	—	—	—	-424M	-530M	-751M	-325M	-491M
Investing cash flow	-39M	98M	-121M	-67M	23M	142M	57M	-495M	-383M	-251M	-487M	-505M
Dividends paid	-261M	-262M	-261M	-266M	-268M	-265M	-265M	-268M	-265M	-263M	-262M	-266M
Share repurchases	0	0	0	—	-50M	-134M	-148M	-105M	-148M	-150M	-147M	-173M
Financing cash flow	976M	-3B	548M	-684M	922M	-2.2B	1.4B	-1.6B	51M	-2.7B	1.4B	-1.8B
Net change in cash	3.1B	168M	-289M	-2.3B	2.6B	-1.4B	684M	471M	-758M	65M	88M	157M
Free cash flow	-1.1B	3.3B	-860M	1.3B	-1.4B	2.4B	-1.4B	2.1B	-956M	2.2B	-1.2B	2B

Feb 25, 2011	3:1
May 30, 2007	3:1

Nutrien Ltd. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Split history

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement